Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $18.0 million.

  • Mesa Laboratories' Free Cash Flow rose 407.72% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $37.9 million, marking a year-over-year decrease of 1175.61%. This contributed to the annual value of $42.6 million for FY2025, which is 238.9% up from last year.
  • Per Mesa Laboratories' latest filing, its Free Cash Flow stood at $18.0 million for Q4 2025, which was up 407.72% from $7.1 million recorded in Q3 2025.
  • Mesa Laboratories' Free Cash Flow's 5-year high stood at $18.0 million during Q4 2025, with a 5-year trough of -$3.0 million in Q2 2022.
  • Over the past 5 years, Mesa Laboratories' median Free Cash Flow value was $9.4 million (recorded in 2023), while the average stood at $9.0 million.
  • As far as peak fluctuations go, Mesa Laboratories' Free Cash Flow crashed by 13397.49% in 2022, and later skyrocketed by 41847.83% in 2023.
  • Mesa Laboratories' Free Cash Flow (Quarter) stood at $13.8 million in 2021, then plummeted by 56.18% to $6.1 million in 2022, then soared by 71.62% to $10.4 million in 2023, then skyrocketed by 66.39% to $17.3 million in 2024, then grew by 4.08% to $18.0 million in 2025.
  • Its last three reported values are $18.0 million in Q4 2025, $7.1 million for Q3 2025, and $884000.0 during Q2 2025.